From: Value of next-generation sequencing in inherited arrhythmia syndromes
ACMG/AMP class (2015) | NGS (nā=ā19) | Sanger (nā=ā70) | |
---|---|---|---|
Pathogenic | 0 (0.0%) | Ā | 29 (41.4%) |
Likely pathogenic | 2 (10.5%) | 3 (4.3%) | |
Likely benign | 0 (0.0%) | 12 (17.1%) | |
Benign | 0 (0.0%) | 0 (0.0%) | |
Uncertain significance | 17 (89.5%) | 26 (37.1%) |
Inherited arrhythmia-related mutation | Ā | nā=ā18 | Ā | Ā | nā=ā33 | Ā |
---|---|---|---|---|---|---|
Ā | RYR2 | 4 | CPVT | CASQ2 | 6 | CPVT, NCCM, HCM |
SCN5A | 2 | BrS, LQTS 3 | LDB3 | 4 | ARVC, HCM, DCM | |
SCN4B | 2 | LQTS10 | APOA5 | 3 | FAF | |
DSP | 2 | ARVC, DCM | SCN5A | 3 | BrS, LQTS | |
GPD1L | 2 | BrS 2 | TRDN | 3 | CPVT, LQTS | |
AKAP9 | 1 | LQTS 11 | CACNA1C | 2 | BrS, LQTS | |
DSC2 | 1 | ARVC 11 | CACNB2 | 2 | BrS | |
KCND3 | 1 | BrS 9 | DSC2 | 2 | ARVC, FAF, DCM | |
KCNE3 | 1 | BrS 6 | DSP | 2 | ARVC, DCM | |
PKP2 | 1 | ARVC 9 | RYR1 | 2 | ARVC | |
SNTA1 | 1 | LQTS 12 | ANK2 | 1 | LQTS | |
Ā | JUP | 1 | ARVC, DCM | |||
TMEM43 | 1 | ARVC | ||||
TRPM4 | 1 | BrS | ||||
Basic NGS ability | Reference | 18/18 (100%) | 15/33 (45.4%) | |||
Extended NGS ability | Reference | 18/18 (100%) | 28/33 (84.8%) |
General mutation | Ā | nā=ā1 | Ā | Ā | nā=ā37 | Ā |
---|---|---|---|---|---|---|
Ā | LMNA | 1 | DCM 1A | APOB | 7 | FHC |
Ā | Ā | LAMA2 | 4 | DCM | ||
RBM20 | 4 | DCM | ||||
GCKR | 3 | FHC | ||||
MYH6 | 3 | FAF, HCM, DCM | ||||
SDHA | 3 | DCM | ||||
LAMA4 | 2 | DCM | ||||
MYBPC3 | 2 | NCCM, HCM, DCM | ||||
ALMS1 | 1 | DCM | ||||
BAG3 | 1 | DCM | ||||
CETP | 1 | FHC | ||||
FBN1 | 1 | AVD, FAA, Marfan Syndrome | ||||
MAP2K2 | 1 | Noonan Syndrome, HCM | ||||
MYH7 | 1 | RCM, NCCM, HCM, DCM | ||||
NEXN | 1 | HCM, DCM | ||||
PRDM16 | 1 | NCCM, DCM | ||||
TMPO | 1 | DCM | ||||
Basic NGS ability | 0/1 (0.0%) | 0/37 (0.0%) | ||||
Extended NGS ability | 1/1 (100%) | 11/37 (29.7%) |